Search

everythinglearnresearchcommunity

for

Search:↓

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Lgr5 is a marker for active, long-lasting stem cells in mouse hair follicles.

Proinflammatory fibroblasts and vascular endothelial cells are key in keloid development.

Lymphoma should be considered in unusual scalp hair loss cases, as treatment can work but may lead to severe complications.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

A 16-year-old boy with Castleman's disease and lupus was successfully treated and showed no recurrence.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

Certain immune cells, when activated by specific signals, can encourage hair growth.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

ITK inhibitors may effectively treat alopecia areata.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Targeting regulatory T cells may help treat age-related diseases.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Langerhans cells are crucial for skin immunity and allergic reactions.

Sparse hairless patches can develop and stabilize in alopecia areata under certain conditions.

A specific group of stem cells can help regenerate hair continuously.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

The research found specific genes that are more active in balding cells, which could be causing hair loss.